"Efficacy and Safety of Palbociclib in Patients with Estrogen Receptor-positive/human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer with Preexisting Conditions: A Post Hoc Analysis of PALOMA-2" by Reshma Mahtani

Article

Efficacy and Safety of Palbociclib in Patients with Estrogen Receptor-positive/human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer with Preexisting Conditions: A Post Hoc Analysis of PALOMA-2

Breast (2021)

Reshma Mahtani, Baptist Health South Florida
Karen Gelmon
Janice M. Walshe
Anil A. Joy
Meghan S Karuturi
Patrick Neven
Dongrui Ray Lu
Sindy Kim, Pfizer
Patrick Schnell
Eustratios Bananis
Lee Schwartzberg

Link

Disciplines

Medicine and Health Sciences

Publication Date

2021

Citation Information

Reshma Mahtani, Karen Gelmon, Janice M. Walshe, Anil A. Joy, et al.. "Efficacy and Safety of Palbociclib in Patients with Estrogen Receptor-positive/human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer with Preexisting Conditions: A Post Hoc Analysis of PALOMA-2" Breast Vol. 59 (2021) p. 321 - 326
Available at: http://works.bepress.com/reshma-mahtani/98/